Gone with the Wind of PE: Life Sciences Sets Sail medium.datadriveninvestor.com Post date January 3, 2024 No Comments on Gone with the Wind of PE: Life Sciences Sets Sail External Tags Healthcare, innovation, mergers-and-acquisitions, private-equity, supply-chain
Sliding Doors of Strategy: Keeping an Open Future with Digital medium.datadriveninvestor.com Post date December 18, 2023 No Comments on Sliding Doors of Strategy: Keeping an Open Future with Digital External Tags digital-transformation, history, mergers-and-acquisitions, strategy, supply-chain
Fast M&A, Furious Supply Chains: Pharma’s Race for Resilience medium.datadriveninvestor.com Post date December 6, 2023 No Comments on Fast M&A, Furious Supply Chains: Pharma’s Race for Resilience External Tags corporate-innovation, innovation, mergers-and-acquisitions, pharmaceuticals-industry, strategy
Is 2023 a Turning Point for Life Sciences M&A Strategies? medium.datadriveninvestor.com Post date December 4, 2023 No Comments on Is 2023 a Turning Point for Life Sciences M&A Strategies? External Tags innovation, mergers-and-acquisitions, pharmaceuticals-industry, strategy, therapeutics
Checkmate or Stalemate? The Global Healthcare M&A Chess Game medium.datadriveninvestor.com Post date May 24, 2023 No Comments on Checkmate or Stalemate? The Global Healthcare M&A Chess Game External Tags business-strategy, change, Healthcare, mergers-and-acquisitions, pharma
SkillenaiSkillenai